Lead Product(s) : Acellular Tissue Engineered Vessel
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Humacyte Launches Symvess for Extremity Vascular Trauma
Details : Symvess is an acellular tissue engineered vessel for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss..
Product Name : Symvess
Product Type : Other Large Molecule
Upfront Cash : Inapplicable
February 26, 2025
Lead Product(s) : Acellular Tissue Engineered Vessel
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Iloprost
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
FDA Approves First Medication to Treat Severe Frostbite
Details : Aurlumyn (iloprost) is a prostanoid IP receptor agonist, acts as vasodilator that opens blood vessels and stops blood clotting. It is indicated for the treatment of severe frostbite in adults.
Product Name : Aurlumyn
Product Type : HPAPI
Upfront Cash : Inapplicable
February 14, 2024
Lead Product(s) : Iloprost
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable